Evaluating the Genetic Component of Ischemic Stroke Subtypes A Family History Study
Background and Purpose— Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and...
Saved in:
Published in | Stroke (1970) Vol. 34; no. 6; pp. 1364 - 1369 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
01.06.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background and Purpose—
Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies.
Methods—
One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.
Results—
A family history of stroke at ≤65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36;
P
<0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97;
P
=0.003). When only cases aged ≤65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) (
P
<0.001) and 3.15 (95% CI, 1.81 to 5.50) (
P
<0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology.
Conclusions—
A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest. |
---|---|
AbstractList | Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies.
One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.
A family history of stroke at < or =65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P<0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P=0.003). When only cases aged <or =65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) (P<0.001) and 3.15 (95% CI, 1.81 to 5.50) (P<0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology.
A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest. Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies.BACKGROUND AND PURPOSETwin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies.One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.METHODSOne thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.A family history of stroke at < or =65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P<0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P=0.003). When only cases aged <or =65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) (P<0.001) and 3.15 (95% CI, 1.81 to 5.50) (P<0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology.RESULTSA family history of stroke at < or =65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P<0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P=0.003). When only cases aged <or =65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) (P<0.001) and 3.15 (95% CI, 1.81 to 5.50) (P<0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology.A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest.CONCLUSIONSA family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest. Background and Purpose— Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies. Methods— One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Results— A family history of stroke at ≤65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P <0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P =0.003). When only cases aged ≤65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) ( P <0.001) and 3.15 (95% CI, 1.81 to 5.50) ( P <0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology. Conclusions— A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest. |
Author | Jerrard-Dunne, Paula Hassan, Ahamad Markus, Hugh S. Cloud, Geoffrey |
Author_xml | – sequence: 1 givenname: Paula surname: Jerrard-Dunne fullname: Jerrard-Dunne, Paula organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK – sequence: 2 givenname: Geoffrey surname: Cloud fullname: Cloud, Geoffrey organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK – sequence: 3 givenname: Ahamad surname: Hassan fullname: Hassan, Ahamad organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK – sequence: 4 givenname: Hugh S. surname: Markus fullname: Markus, Hugh S. organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14881735$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12714707$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0U1LxDAQBuAgiq4ff0GKoLfWTJK2qXhQVlcFQXD3HtLsRKv9WJtU8N-bdVcWPJlLIDwzYebdJ9tt1yIhJ0ATgAzOKSTT2XNClycrcsYTyAspksnNFhlBykQsMia3yYhSXsRMFMUe2XfuLXDGZbpL9oDlIHKaj8jl7aeuB-2r9iXyrxjdYYu-MtG4axbh19ZHnY0enHnFJrxOfd-9YzQdSv-1QHdIdqyuHR6t7wMym9zOxvfx49Pdw_j6MTZcgo_nGZdZhoYLxkGWDHOZFnZuOCLPUJaFRskNtYJTYABUgjZlajPA1KZg-QE5W7Vd9N3HgM6rpnIG61q32A1O5VzQsJgiwOM1HMoG52rRV43uv9TvuAGcroF2Rte2162p3MYJKSHnaXAXK2f6zrke7YZQtcxAUVAhA7XJQP1koCY3ofjqT7GpfNhw1_peV_V_WnwD2UCMmQ |
CODEN | SJCCA7 |
CitedBy_id | crossref_primary_10_1007_s00439_024_02717_7 crossref_primary_10_1016_j_jns_2009_03_015 crossref_primary_10_1007_BF03256279 crossref_primary_10_1111_j_1747_4949_2009_00281_x crossref_primary_10_1177_1051228405001473 crossref_primary_10_1007_s12975_010_0041_5 crossref_primary_10_5535_arm_2015_39_6_980 crossref_primary_10_1007_s12013_014_0099_x crossref_primary_10_1371_journal_pone_0159811 crossref_primary_10_4199_C00052ED1V01Y201204GMM001 crossref_primary_10_1161_STROKEAHA_119_024151 crossref_primary_10_1002_gepi_21729 crossref_primary_10_1177_0193945920957935 crossref_primary_10_3390_ijms21249729 crossref_primary_10_1186_1471_2350_14_17 crossref_primary_10_1016_j_thromres_2014_07_025 crossref_primary_10_1097_01_mol_0000162324_85290_ac crossref_primary_10_3889_oamjms_2016_114 crossref_primary_10_1016_j_jstrokecerebrovasdis_2008_11_004 crossref_primary_10_1177_1076029617736383 crossref_primary_10_1016_j_jstrokecerebrovasdis_2007_11_001 crossref_primary_10_1038_nrneurol_2014_196 crossref_primary_10_1111_ene_12827 crossref_primary_10_1113_expphysiol_2007_038752 crossref_primary_10_1212_01_wnl_0000252955_17126_6a crossref_primary_10_1042_CS20160825 crossref_primary_10_1097_HJR_0b013e328330be77 crossref_primary_10_1001_archneurol_2011_99 crossref_primary_10_1097_JCMA_0000000000000598 crossref_primary_10_1016_j_jacc_2010_02_051 crossref_primary_10_1038_ng_1081 crossref_primary_10_1177_1470320309360816 crossref_primary_10_1007_s12013_014_9878_7 crossref_primary_10_1097_MBC_0b013e3282010ad0 crossref_primary_10_1373_clinchem_2006_073494 crossref_primary_10_1038_aps_2010_141 crossref_primary_10_1590_S1980_57642011DN05040003 crossref_primary_10_1097_MOP_0b013e3282f1883b crossref_primary_10_1155_2012_839151 crossref_primary_10_5853_jos_2015_17_1_7 crossref_primary_10_1038_s41598_017_14355_3 crossref_primary_10_1080_13102818_2020_1809518 crossref_primary_10_1016_j_jstrokecerebrovasdis_2014_06_015 crossref_primary_10_1186_1471_2350_9_110 crossref_primary_10_1186_1471_2377_5_20 crossref_primary_10_1186_1471_2350_8_60 crossref_primary_10_1016_j_cacc_2005_04_003 crossref_primary_10_1016_S1474_4422_07_70028_5 crossref_primary_10_1007_s12031_015_0580_z crossref_primary_10_1016_j_nrl_2013_04_005 crossref_primary_10_1016_j_atherosclerosis_2008_02_025 crossref_primary_10_1111_j_1600_0404_2006_00672_x crossref_primary_10_1016_j_nrleng_2013_04_004 crossref_primary_10_4103_1673_5374_228729 crossref_primary_10_2217_pgs_12_14 crossref_primary_10_1042_BSR20171088 crossref_primary_10_1002_gepi_20171 crossref_primary_10_1159_000540085 crossref_primary_10_1002_humu_20666 crossref_primary_10_1007_s12017_014_8330_x crossref_primary_10_1007_s12031_013_0078_5 crossref_primary_10_1161_STROKEAHA_115_009341 crossref_primary_10_1093_hmg_ddr345 crossref_primary_10_1016_j_jstrokecerebrovasdis_2019_05_006 crossref_primary_10_1186_s12879_017_2455_0 crossref_primary_10_4061_2011_179061 crossref_primary_10_1016_j_thromres_2011_11_030 crossref_primary_10_1016_j_jns_2007_01_037 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_106151 crossref_primary_10_1007_s11684_010_0013_x crossref_primary_10_1016_j_clineuro_2006_09_005 crossref_primary_10_1007_s11883_013_0342_8 crossref_primary_10_1016_j_bbacli_2014_12_004 crossref_primary_10_1038_ejhg_2008_27 crossref_primary_10_1016_j_jns_2009_06_013 crossref_primary_10_1089_omi_2015_0083 crossref_primary_10_1111_j_1755_5949_2011_00292_x crossref_primary_10_1002_ana_24840 crossref_primary_10_1186_s12905_021_01305_5 crossref_primary_10_1007_s12031_015_0520_y crossref_primary_10_1007_s12035_013_8561_0 crossref_primary_10_1160_TH14_06_0566 crossref_primary_10_1007_s12035_016_9903_5 crossref_primary_10_1016_j_brainres_2019_146594 crossref_primary_10_1080_00207454_2019_1688810 crossref_primary_10_3109_00207454_2014_951042 crossref_primary_10_1212_WNL_0000000000000705 crossref_primary_10_1111_ene_12508 crossref_primary_10_1016_j_acvd_2014_07_047 crossref_primary_10_1093_hmg_ddp582 crossref_primary_10_1161_STROKEAHA_115_009485 crossref_primary_10_1002_ana_21480 crossref_primary_10_1097_CRD_0b013e318239b924 crossref_primary_10_2298_ABS0704303S crossref_primary_10_1097_00008480_200312000_00002 crossref_primary_10_1007_s00415_006_0048_8 crossref_primary_10_1177_1535370213494650 crossref_primary_10_1111_j_1755_5949_2012_00322_x crossref_primary_10_1111_j_1600_0404_2008_01127_x crossref_primary_10_1016_S1474_4422_12_70234_X crossref_primary_10_1016_j_numecd_2023_01_009 crossref_primary_10_1007_s10072_010_0330_5 crossref_primary_10_1371_journal_pmed_1000225 crossref_primary_10_1016_j_neulet_2005_12_078 crossref_primary_10_1016_S1474_4422_21_00031_4 crossref_primary_10_1371_journal_pone_0090255 crossref_primary_10_1016_S1474_4422_03_00479_4 crossref_primary_10_1055_s_0040_1717116 crossref_primary_10_1371_journal_pone_0001043 crossref_primary_10_1038_nrneurol_2011_80 crossref_primary_10_1371_journal_pgen_1004469 crossref_primary_10_1016_j_pmu_2015_03_002 crossref_primary_10_1186_1741_7015_10_113 crossref_primary_10_1007_s12031_016_0773_0 crossref_primary_10_1371_journal_pone_0136352 crossref_primary_10_1111_ene_12365 crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_05_013 crossref_primary_10_1111_ene_12881 crossref_primary_10_1212_01_wnl_0000178744_42953_b7 crossref_primary_10_1016_S1474_4422_14_70029_8 crossref_primary_10_1038_ng_2397 crossref_primary_10_1177_1747493017743062 crossref_primary_10_1542_peds_2004_1905 crossref_primary_10_1111_j_1747_4949_2010_00422_x crossref_primary_10_1161_STROKEAHA_116_013148 crossref_primary_10_1161_STROKEAHA_115_009387 crossref_primary_10_1007_s12035_015_9332_x crossref_primary_10_1016_j_gene_2015_06_036 crossref_primary_10_1080_00207454_2020_1732964 crossref_primary_10_1134_S0362119717080047 crossref_primary_10_1371_journal_pone_0021439 crossref_primary_10_1016_j_jfma_2013_12_004 crossref_primary_10_1007_s11883_009_0027_5 crossref_primary_10_1111_j_1538_7836_2008_03097_x crossref_primary_10_3892_br_2018_1104 crossref_primary_10_1371_journal_pone_0056478 crossref_primary_10_1161_JAHA_115_003003 crossref_primary_10_3390_ijerph13101016 |
Cites_doi | 10.1161/str.25.9.8073453 10.1093/oxfordjournals.aje.a114224 10.1136/jnnp.62.1.66 10.1161/str.23.2.1561651 10.1161/str.19.11.3188119 10.1093/oxfordjournals.aje.a121625 10.1161/atvb.17.11.2880 10.1161/str.33.3.769 10.1161/str.17.6.3810726 10.1161/circ.91.2.365 10.1056/NEJM198708273170901 10.1093/brain/123.9.1784 10.1161/str.32.12.2939 10.1161/str.24.9.8362432 10.1093/oxfordjournals.aje.a113657 10.1161/str.28.7.1361 10.1097/00004647-200107000-00001 10.1161/str.26.8.1329 10.1161/str.25.8.8042210 10.1159/000110355 10.1161/circ.84.3.1884448 10.1016/S0022-510X(01)00691-8 10.1136/bmj.307.6918.1541 |
ContentType | Journal Article |
Copyright | 2003 INIST-CNRS |
Copyright_xml | – notice: 2003 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/01.STR.0000069723.17984.FD |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
EndPage | 1369 |
ExternalDocumentID | 12714707 14881735 10_1161_01_STR_0000069723_17984_FD |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | London |
GeographicLocations_xml | – name: London |
GroupedDBID | --- .3C .55 .GJ .XZ .Z2 01R 0R~ 123 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ A9M AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAUEB AAXQO AAYEP AAYJJ AAYXX ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFS ACGOD ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADGHP ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BCGUY BOYCO BQLVK BS7 C45 CITATION CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B M18 N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YQJ YYP ZB8 ZGI ZZMQN IQODW ACIJW AWKKM CGR CUY CVF ECM EIF NPM OJAPA OLW RHF YCJ 7X8 |
ID | FETCH-LOGICAL-c381t-d63866ec342318b2e7859fdc3ee36e8b9ae83c0f4301211081acb5f61e5f51f3 |
ISSN | 0039-2499 1524-4628 |
IngestDate | Fri Jul 11 09:10:10 EDT 2025 Wed Feb 19 01:44:26 EST 2025 Mon Jul 21 09:17:26 EDT 2025 Thu Apr 24 23:12:21 EDT 2025 Tue Jul 01 01:13:42 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Human stroke classification Nervous system diseases risk factors Family study Cardiovascular disease Case control study Epidemiology Cerebral disorder Vascular disease Phenotype genetics Ischemia cerebral infarction Central nervous system disease Classification Risk factor Cerebrovascular disease Brain (vertebrata) |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c381t-d63866ec342318b2e7859fdc3ee36e8b9ae83c0f4301211081acb5f61e5f51f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 12714707 |
PQID | 73401169 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_73401169 pubmed_primary_12714707 pascalfrancis_primary_14881735 crossref_primary_10_1161_01_STR_0000069723_17984_FD crossref_citationtrail_10_1161_01_STR_0000069723_17984_FD |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2003-06-01 |
PublicationDateYYYYMMDD | 2003-06-01 |
PublicationDate_xml | – month: 06 year: 2003 text: 2003-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Stroke (1970) |
PublicationTitleAlternate | Stroke |
PublicationYear | 2003 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_20_2 e_1_3_2_10_2 e_1_3_2_21_2 e_1_3_2_5_2 e_1_3_2_22_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_23_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_24_2 e_1_3_2_2_2 e_1_3_2_14_2 (e_1_3_2_11_2) 1999; 4 |
References_xml | – ident: e_1_3_2_7_2 doi: 10.1161/str.25.9.8073453 – ident: e_1_3_2_10_2 doi: 10.1093/oxfordjournals.aje.a114224 – ident: e_1_3_2_14_2 doi: 10.1136/jnnp.62.1.66 – ident: e_1_3_2_1_2 doi: 10.1161/str.23.2.1561651 – ident: e_1_3_2_15_2 doi: 10.1161/str.19.11.3188119 – ident: e_1_3_2_8_2 doi: 10.1093/oxfordjournals.aje.a121625 – ident: e_1_3_2_21_2 doi: 10.1161/atvb.17.11.2880 – ident: e_1_3_2_2_2 doi: 10.1161/str.33.3.769 – ident: e_1_3_2_22_2 doi: 10.1161/str.17.6.3810726 – ident: e_1_3_2_24_2 doi: 10.1161/circ.91.2.365 – ident: e_1_3_2_9_2 doi: 10.1056/NEJM198708273170901 – ident: e_1_3_2_5_2 doi: 10.1093/brain/123.9.1784 – ident: e_1_3_2_19_2 doi: 10.1161/str.32.12.2939 – ident: e_1_3_2_3_2 doi: 10.1161/str.24.9.8362432 – ident: e_1_3_2_16_2 doi: 10.1093/oxfordjournals.aje.a113657 – ident: e_1_3_2_4_2 doi: 10.1161/str.28.7.1361 – ident: e_1_3_2_18_2 doi: 10.1097/00004647-200107000-00001 – ident: e_1_3_2_20_2 doi: 10.1161/str.26.8.1329 – ident: e_1_3_2_13_2 doi: 10.1161/str.25.8.8042210 – ident: e_1_3_2_17_2 doi: 10.1159/000110355 – ident: e_1_3_2_23_2 doi: 10.1161/circ.84.3.1884448 – ident: e_1_3_2_12_2 doi: 10.1016/S0022-510X(01)00691-8 – ident: e_1_3_2_6_2 doi: 10.1136/bmj.307.6918.1541 – volume: 4 start-page: 313 year: 1999 ident: e_1_3_2_11_2 publication-title: J Epidemiol Biostat |
SSID | ssj0002385 |
Score | 2.217642 |
Snippet | Background and Purpose—
Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is... Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 1364 |
SubjectTerms | Aged Biological and medical sciences Brain Ischemia - classification Brain Ischemia - epidemiology Brain Ischemia - genetics Case-Control Studies European Continental Ancestry Group - genetics Family Female Gene Frequency Humans Ischemic Attack, Transient - epidemiology Ischemic Attack, Transient - genetics London - epidemiology Male Medical sciences Middle Aged Multivariate Analysis Neurology Odds Ratio Risk Risk Factors Sample Size Stroke - classification Stroke - epidemiology Stroke - genetics Vascular Diseases - epidemiology Vascular Diseases - genetics Vascular diseases and vascular malformations of the nervous system |
Subtitle | A Family History Study |
Title | Evaluating the Genetic Component of Ischemic Stroke Subtypes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/12714707 https://www.proquest.com/docview/73401169 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkRASQrwJj7IHbsgm6_WTW0UbRUVFghipN2tfVqvSOIrtQ_vrmX0461AiFS5WZGdta-fb8czszDcIfQCVx7KEyyBKIhnEIpFBDlZ_oCTXMTcxrakuTj75ls5_xsenyakP6Jvqko6H4vqvdSX_I1U4B3LVVbL_INnNTeEE_Ab5whEkDMdbyfjIUXW7iif4ny5JNGnizdJt8p-D-2oS4Ntu3Vyoj23Pddi1tVXOLr5hWYevRmSzzl5d2EGazanIpqOwwbHS_eFloA1gNaQYjrJ-ml66kLupFPOKrm1tyPXgjF0y6QPi64veQGquuwYttoIR1CdNhcop0CgOdL3rWMO6cOX5DXVJqKUwv6nHU2JqE8JF-cNSTKa6PVqo6dXicHY4HgTztbo0EiZRRuLMdtH9g0V7uHQX3YvAodC9Lr5-97zyYLgkjpIWHv1p94M1yay71ZYl83DFWlhUte2GsttdMWZL-Rg9cv4GPrDgeYLuqOVTdP_EZVQ8Q6XHEAYMYYchvMEQbmo8YAhbDOEBQ58xwxZB2CEIGwQ9R-XsqPwyD1ynjUCAxdYFErRwmiqh6SBJziOV5UlRS0GVoqnKecFUrtdtTA0lIJiRTPCkTolK6oTU9AXaW8I7vdKZcqxgaZyxKTiqAj4HnOcqN2GGPJJSTFAxTFolHAu9bobyqzLeaEqqKalg7is_95WZ-2p2OEF0M3ZluVhuNWp_SzZ-KHy7SEaTCXo_CKsC3ao3zNhSNX1bZTTW-5TFBL20MvRjHQZe77zyBj3wC-Qt2uvWvXoH9mvH9w30fgPCg5Mc |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluating+the+genetic+component+of+ischemic+stroke+subtypes%3A+a+family+history+study&rft.jtitle=Stroke+%281970%29&rft.au=Jerrard-Dunne%2C+Paula&rft.au=Cloud%2C+Geoffrey&rft.au=Hassan%2C+Ahamad&rft.au=Markus%2C+Hugh+S&rft.date=2003-06-01&rft.eissn=1524-4628&rft.volume=34&rft.issue=6&rft.spage=1364&rft_id=info:doi/10.1161%2F01.STR.0000069723.17984.FD&rft_id=info%3Apmid%2F12714707&rft.externalDocID=12714707 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |